Barclays PLC Dexcom Inc Put Options Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$64.0 - $116.06 $2.24 Million - $4.06 Million	35,000 New	35,000 $2.35 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $24.4 Million - $29.9 Million	-213,200 Reduced 85.73%	35,500 $4.92 Million
Q4 2023 Feb 15, 2024	BUY	$75.49 - $124.16 $18.8 Million - $30.9 Million	248,700 New	248,700 $30.9 Million
Q1 2023 May 04, 2023	SELL	$104.0 - $122.92 $384,800 - $454,804	-3,700 Reduced 2.06%	175,500 $20.4 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $15.2 Million - $22 Million	179,200 New	179,200 $20.3 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $649,350 - $814,100	5,000 Added 5000.0%	5,100 $2.74 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $1.91 Million - $3.02 Million	-39,900 Reduced 99.75%	100 $27,000
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $487,200 - $681,100	17,500 Added 77.78%	40,000 $5.99 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $642,125 - $1.01 Million	-27,500 Reduced 55.0%	22,500 $3.22 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $859,460 - $1.24 Million	49,000 Added 4900.0%	50,000 $4.75 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $172,392 - $244,728	-13,200 Reduced 92.96%	1,000 $74,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $152,344 - $210,706	13,700 Added 2740.0%	14,200 $815,000
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $5,680 - $9,490	500	500 $24,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.